首页> 外文期刊>Clinical and experimental medicine >A clinical analysis of 114 cases of sarcomatoid carcinoma of the lung
【24h】

A clinical analysis of 114 cases of sarcomatoid carcinoma of the lung

机译:114例肺部肉瘤样癌癌的临床分析

获取原文
获取原文并翻译 | 示例
           

摘要

The aim was to investigate the clinicopathological characteristics, diagnosis, and prognosis of sarcomatoid carcinoma of the lung. We reviewed 114 cases of sarcomatoid carcinoma of the lung in patients that were admitted to the First Affiliated Hospital of Zhengzhou University and Anyang Tumor Hospital from January 2009 to March 2018. We analyzed the clinical characteristics, immunohistochemical profiles, treatments, and overall survival of the patients. The patient population included 88 men and 26 women. Median patient age was 65?years (range 37–88?years), and the gender ratio (M/F) was 3.4:1. Median survival was 3.5?months (range 0.5–60?months). Univariate analysis showed that tumor location, tumor size, M stage, TNM stage, chemotherapy, and surgery were all prognostic factors for survival ( P ?
机译:目的是探讨肺部胸壁样癌癌的临床病理特征,诊断和预后。我们在2009年1月至2018年3月从2009年至3月录取了郑州大学和安阳肿瘤医院第一个附属医院的患者中审查了114例肺癌患者。我们分析了临床特征,免疫组化谱,治疗和整体生存耐心。患者人口包括88名男性和26名女性。中位数患者年龄为65岁?年(范围37-88?年),性别比率(M / F)为3.4:1。中位生存率为3.5?月(范围0.5-60?月)。单变量分析表明,肿瘤定位,肿瘤大小,M阶段,TNM阶段,化疗和手术是存活的预后因素(P?<?0.05)。我们发现T阶段,手术和化疗是SarcomaToid癌的独立预后因素(P?<?0.05)。肺瘤样癌是一种罕见的肿瘤,预后差。 T阶段较小,完全切除和化疗患者表现出更好的预后。早期诊断和早期治疗对于改善这些患者的预后是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号